Professional
Added to YB: 2026-03-20
Pitch date: 2026-02-19
MDRX [neutral]
Veradigm Inc.
+5.81%
current return
Author Info
No bio for this author
Company Info
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.
Market Cap
$773.6M
Pitch Price
$4.30
Price Target
11.00 (+142%)
Dividend
N/A
EV/EBITDA
9.90
P/E
-25.28
EV/Sales
0.93
Sector
Health Care Technology
Category
value
McIntyre Partnerships Portfolio Holding: Veradigm Inc.
MDRX (holding update): Repurchased Q1 2025 after failed sale process. $4.50 stock w/ $1/sh net cash, $1/sh other investments, $0.50-$0.70/sh norm FCF (~30% FCF/EV yield). Relisting expected 2026. Trades 0.7x EV/Sales vs SaaS peers 4-5x. PT $7-$11 at 15x norm FCF post-relist; strategic sale could add $1/sh FCF from $120M synergies, supporting $10+ takeout.
Read full article (2 min)